Share on StockTwits

Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) announced a quarterly dividend on Friday, August 1st, Analyst Ratings Network reports. Investors of record on Thursday, August 21st will be paid a dividend of 0.353 per share on Thursday, September 4th. This represents a $1.41 annualized dividend and a dividend yield of 2.61%. The ex-dividend date is Tuesday, August 19th.

TEVA has been the subject of a number of recent research reports. Analysts at Canaccord Genuity raised their price target on shares of Teva Pharmaceutical Industries Ltd from $55.70 to $58.00 in a research note on Friday. They now have a “hold” rating on the stock. On the ratings front, analysts at BMO Capital Markets raised their price target on shares of Teva Pharmaceutical Industries Ltd from $57.00 to $59.00 in a research note on Thursday. Finally, analysts at Sterne Agee raised their price target on shares of Teva Pharmaceutical Industries Ltd from $53.00 to $56.00 in a research note on Wednesday. Nine analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $57.58.

Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) traded up 0.97% on Friday, hitting $54.02. 6,061,683 shares of the company’s stock traded hands. Teva Pharmaceutical Industries Ltd has a 1-year low of $36.26 and a 1-year high of $55.70. The stock’s 50-day moving average is $53.5 and its 200-day moving average is $49.98. The company has a market cap of $45.955 billion and a P/E ratio of 33.05.

Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) last issued its quarterly earnings data on Thursday, July 31st. The company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.02. The company had revenue of $5.00 billion for the quarter, compared to the consensus estimate of $5.08 billion. During the same quarter in the previous year, the company posted $1.20 earnings per share. The company’s revenue for the quarter was up 2.5% on a year-over-year basis. On average, analysts predict that Teva Pharmaceutical Industries Ltd will post $4.82 earnings per share for the current fiscal year.

Teva Pharmaceutical Industries Ltd (NASDAQ:TEVA) is an Israel-based pharmaceutical and drug company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.